Gut Healing — Benefits Deep Dive

Gut healing is the practical project of restoring an intestinal epithelium that has lost its barrier integrity — the condition popularized as "leaky gut" and formalized in the medical literature as increased intestinal permeability. The single-cell-thick epithelial monolayer separating the gut lumen from systemic circulation is the largest mucosal surface in the body (approximately 32 square meters in adults) and the site where dietary, microbial, and immunological inputs are continuously negotiated. When tight junctions fail, undigested food peptides and microbial antigens translocate into the lamina propria and drive chronic low-grade systemic inflammation. The four deep-dive pages below cover the four most evidence-supported interventions for restoring barrier function: a structured elimination-and-reintroduction diet (GAPS), the amino acid that is the primary fuel of enterocytes (glutamine, delivered via bone broth and isolated supplementation), the bacterial strains with the strongest barrier-repair evidence (Lactobacillus rhamnosus GG, Saccharomyces boulardii, multi-strain VSL#3-class formulations), and the practical work of identifying and removing the specific triggers (NSAIDs, alcohol, gluten, glyphosate, chronic stress) that perpetuate epithelial damage.

Deep-Dive Articles

Back to Table of Contents

Table of Contents

1. Deep-Dive Articles
2. Why Gut Healing Requires a Multi-Pronged Approach
3. Research Papers: Dietary Interventions (GAPS, SCD, Low-FODMAP)
4. Research Papers: Glutamine and Bone Broth
5. Research Papers: Probiotic Strain-Specific Evidence
6. Research Papers: Triggers and Permeability
7. Research Papers: Cross-Cutting (Barrier Biology, Microbiome)
8. External Authoritative Resources
9. Connections

Why Gut Healing Requires a Multi-Pronged Approach

Increased intestinal permeability does not arise from a single cause and rarely resolves through a single intervention. The intestinal epithelium is a dynamic tissue with a turnover cycle of three to five days — the entire surface is replaced approximately every week through proliferation in crypt stem cell niches and migration up the villus axis. This high turnover means the barrier can be either rapidly damaged or rapidly restored, depending on the balance of inputs. Three input categories interact:

1. Substrate provision — enterocytes preferentially burn glutamine for ATP, and the tight junction proteins (claudins, occludin, zonula occludens-1) require continuous synthesis from dietary amino acids. Inadequate protein intake, chronic catabolic illness, or restricted-amino-acid diets impair repair regardless of other interventions. This is the mechanistic case for glutamine-rich bone broth and free L-glutamine supplementation.
2. Microbial signaling — commensal bacteria signal continuously to the epithelium via short-chain fatty acid metabolites (butyrate is the primary fuel of colonocytes), pattern-recognition receptor ligands, and direct cell-cell contact. Dysbiosis (loss of butyrate producers, overgrowth of pathobionts) disrupts these signals and degrades the barrier. This is the case for targeted probiotic strains with documented barrier-restoration evidence.
3. Trigger removal — ongoing chemical, mechanical, or immunological injury (NSAIDs, alcohol, gluten in sensitive individuals, chronic stress) prevents repair regardless of nutritional and microbial support. Identifying and removing the active drivers is necessary but rarely sufficient on its own.

The fourth element — structured dietary reintroduction protocols like GAPS and the Specific Carbohydrate Diet — sits at the intersection of all three. By simultaneously providing dense amino-acid and gelatin substrate, removing fermentable substrate that feeds dysbiotic flora, and acting as a long elimination-and-reintroduction trigger-identification protocol, these structured diets address all three input categories in parallel. The trade-off is high adherence demand and the risk of nutritional inadequacy if the diet is not properly executed.

For a comprehensive overview of the conditions associated with leaky gut and the broader case for barrier restoration, see the main Gut Healing page.

Back to Table of Contents

Research Papers: Dietary Interventions (GAPS, SCD, Low-FODMAP)

1. Suskind DL et al., Specific Carbohydrate Diet for inflammatory bowel disease (J Pediatr Gastroenterol Nutr) — PubMed: SCD for IBD
2. Cohen SA et al., Clinical and mucosal improvement with SCD in pediatric Crohn's disease — PubMed: SCD mucosal healing
3. Halmos EP et al., Low-FODMAP diet RCT for IBS (Gastroenterology) — PubMed: Low-FODMAP RCT
4. Campbell-McBride N, Gut and Psychology Syndrome (GAPS) clinical observations — PubMed: GAPS protocol
5. Konijeti GG et al., Autoimmune Protocol Diet (AIP) for inflammatory bowel disease — PubMed: AIP for IBD
6. Suskind DL et al., Maintenance of remission with SCD in Crohn's disease — PubMed: SCD maintenance
7. Olendzki BC et al., Anti-inflammatory diet for ulcerative colitis case series — PubMed: Anti-inflammatory diet
8. Levine A et al., Crohn's Disease Exclusion Diet (CDED) RCT — PubMed: CDED RCT
9. Catassi G et al., Pediatric food allergy and dietary intervention review — PubMed: Pediatric food allergy
10. Reddel S et al., Impact of Low-FODMAP diet on gut microbiota composition — PubMed: FODMAP microbiota

Back to Table of Contents

Research Papers: Glutamine and Bone Broth

1. Wischmeyer PE, Glutamine and gut barrier function in critical illness — PubMed: Glutamine in critical care
2. van der Hulst RR et al., Glutamine and the preservation of gut integrity (Lancet) — PubMed: van der Hulst Lancet
3. Rao R, Samak G, Role of glutamine in protection of intestinal epithelial tight junctions — PubMed: Glutamine tight junctions
4. Zhou Q et al., Randomized placebo-controlled trial of dietary glutamine supplements for postinfectious IBS — PubMed: Glutamine postinfectious IBS
5. Benjamin J et al., Glutamine in Crohn's disease (intestinal permeability) — PubMed: Glutamine in Crohn's
6. Newsholme P, Why is L-glutamine metabolism important to cells of the immune system — PubMed: Newsholme glutamine immunology
7. Daniel H, Genome-wide analysis of glutamine effect on gene expression in enterocytes — PubMed: Glutamine gene expression
8. Hsu CN et al., Bone broth and glycine in metabolic disease (review) — PubMed: Bone broth nutrition
9. Hou Y et al., Collagen peptide supplementation and gut barrier — PubMed: Collagen peptide barrier
10. Hubl W et al., Glutamine and intestinal mucosal mass — PubMed: Glutamine and mucosal mass

Back to Table of Contents

Research Papers: Probiotic Strain-Specific Evidence

1. Szajewska H et al., Lactobacillus rhamnosus GG meta-analyses (acute diarrhea, antibiotic-associated diarrhea) — PubMed: LGG meta-analysis
2. McFarland LV, Saccharomyces boulardii meta-analysis (CDI, AAD) — PubMed: S. boulardii meta-analysis
3. Gionchetti P et al., VSL#3 for pouchitis (Gastroenterology) — PubMed: VSL#3 pouchitis
4. Tursi A et al., VSL#3 for active ulcerative colitis — PubMed: VSL#3 ulcerative colitis
5. Whorwell PJ et al., Bifidobacterium infantis 35624 in IBS — PubMed: B. infantis 35624 IBS
6. Sanders ME et al., Probiotics and prebiotics in intestinal health and disease (Nat Rev Gastro) — PubMed: Sanders Nat Rev
7. Hill C et al., Expert consensus statement on the scope of probiotics (ISAPP) — PubMed: ISAPP consensus
8. Bron PA et al., Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa — PubMed: Probiotic-host interaction
9. Goldenberg JZ et al., Probiotics for the prevention of Clostridium difficile-associated diarrhea (Cochrane) — PubMed: Probiotics for CDI Cochrane
10. Doron S, Snydman DR, Risk and safety of probiotics — PubMed: Probiotic safety

Back to Table of Contents

Research Papers: Triggers and Permeability

1. Bjarnason I et al., NSAIDs and the small intestine: enteropathy mechanism — PubMed: NSAID enteropathy
2. Bode JC, Bode C, Effect of alcohol consumption on the gut — PubMed: Alcohol and gut permeability
3. Hollon J et al., Effect of gliadin on permeability in celiac and non-celiac patients (Nutrients) — PubMed: Gliadin permeability
4. Drago S et al., Gliadin, zonulin, and gut permeability — PubMed: Gliadin and zonulin
5. Samsel A, Seneff S, Glyphosate, pathways to modern diseases (review of toxicity hypotheses) — PubMed: Glyphosate hypothesis
6. Vanuytsel T et al., Psychological stress and corticotropin-releasing hormone increase intestinal permeability (Gut) — PubMed: Stress and CRH permeability
7. Wallon C et al., Mast cells, CRH and gut barrier function — PubMed: Mast cells and gut barrier
8. Camilleri M, Leaky gut: mechanisms, measurement, and clinical implications in humans — PubMed: Camilleri leaky gut review
9. Fasano A, Zonulin and its regulation of intestinal barrier function — PubMed: Fasano zonulin
10. Bischoff SC et al., Intestinal permeability — a new target for disease prevention and therapy (BMC Gastro) — PubMed: Bischoff permeability review

Back to Table of Contents

Research Papers: Cross-Cutting (Barrier Biology, Microbiome)

1. Turner JR, Intestinal mucosal barrier function in health and disease (Nat Rev Immunol) — PubMed: Turner barrier review
2. Suzuki T, Regulation of intestinal epithelial permeability by tight junctions — PubMed: Suzuki tight junctions
3. Furusawa Y et al., Commensal microbe-derived butyrate induces colonic Tregs (Nature) — PubMed: Butyrate Tregs
4. Atarashi K et al., Treg induction by a rationally selected mixture of Clostridia strains — PubMed: Clostridia and Tregs
5. Sender R et al., Revised estimates for the number of human and bacteria cells in the body — PubMed: Sender microbiome census
6. Sonnenburg JL, Backhed F, Diet-microbiota interactions as moderators of human metabolism — PubMed: Diet-microbiota
7. Vetrano S et al., Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis — PubMed: JAM-A and mucosa
8. Round JL, Mazmanian SK, The gut microbiota shapes intestinal immune responses (Nat Rev Immunol) — PubMed: Round/Mazmanian microbiota immunity
9. Maslowski KM et al., Regulation of inflammatory responses by gut microbiota and short-chain fatty acids — PubMed: Maslowski SCFA
10. Mu Q et al., Leaky gut as a danger signal for autoimmune diseases (Frontiers in Immunology) — PubMed: Mu leaky gut autoimmunity

Back to Table of Contents

External Authoritative Resources

• NIDDK — Digestive Diseases Information (NIH authoritative resource on IBD, IBS, celiac)
• American Gastroenterological Association (AGA guidelines, clinical practice updates)
• Crohn's & Colitis Foundation (patient resources, diet research updates)
• International Scientific Association for Probiotics and Prebiotics (ISAPP)
• PubMed — All research on intestinal permeability / leaky gut

Back to Table of Contents

Connections

• Gut Healing (Main Page)
• GAPS Diet
• Bone Broth and Glutamine
• Probiotic Strains for Repair
• Avoiding Triggers
• All Remedies
• SIBO
• Crohn's Disease
• Celiac Disease
• Irritable Bowel Syndrome (IBS)
• Glutamine
• Glycine
• Bone Broth
• Fermented Foods
• Immune Boosting

Back to Table of Contents